Pfizer is trying to get out of paying billions in taxes. Bernie Sanders isn’t having any of it.
In an official press release, Sanders and his U.S. Senate colleague Tammy Baldwin (D-WI) called on Treasury Secretary Jack Lew to intervene to stop the drug manufacturer from avoiding taxes through a complex tax scheme called transfer pricing.
Through transfer pricing, Pfizer would identify as an Irish corporation for tax purposes by merging with Allergan, a newly acquired pharmaceutical company based in Ireland. Even though Pfizer makes its products in the US, uses American labor to manufacture and test its products, and depends on American infrastructure for everything from research and development to transportation, Pfizer would pay the Irish tax rate on its US profits. The move is estimated to deprive the U.S. Treasury of $35 billion in tax revenue on profits exceeding $118 billion.
“I find it ironic that some of my Republican colleagues, in their internal budget negotiations, claim that $30 billion in deficit-reduction is required for the coming fiscal year,” Sanders said in the release. “Preventing the inversion planned by just one company, Pfizer, could produce more deficit-reduction than the cuts they are demanding.”
Sanders cited a February 2016… Leer más...
↧